Skip to content

Clinical trials

Phase 3 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 3 Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20021
20034
20047
20054
20063
20071
20082
20096
20103
20112
20121
20132
20141
20151
20162
20172
20182
20191
20202
20221
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Not yet recruiting2
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University5
Chestnut Health Systems4
Johns Hopkins University4
Butler Hospital3
Dartmouth-Hitchcock Medical Center3
Norwegian University of Science and Technology3
Boston Medical Center2
Brigham and Women's Hospital2
University of California, Los Angeles2
University of Cincinnati2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders62
Opioid-Related Disorders13
Alcoholism7
HIV Infections6
Cocaine-Related Disorders3
Mental Disorders3
Stress Disorders, Post-Traumatic3
Anxiety Disorders2
Bipolar Disorder2
Chemically-Induced Disorders2

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.